Susan Wood, former director of women’s health for the Food and Drug Administration, spoke about the FDA’s protracted delay of granting over-the-counter status to the emergency contraception Plan B at UNH March 7. Wood, who resigned over the issue, said that the FDA’s decision to delay OTC status to the drug ran counter to significant scientific recommendations. (Carie Schelfhaudt/Media Relations)